|
| Carlos-Rivera, Fernando et al. Economic evaluation of evolocumab in uncontrolled patients with high-risk cardiovascular disease affected by primary hypercholesterolemia and mixed dyslipidemia. Cardiovasc. metab. sci, July 2022, vol.33, no.2, p.52-63. ISSN 2954-3835
|
|